Hualan Biological Engineering financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥320.79M ¥361.28M ¥354.99M ¥351.14M ¥475.16M ¥1.22B ¥1.26B ¥961.40M ¥972.46M ¥1.12B ¥1.24B ¥1.47B ¥1.93B ¥2.37B ¥3.22B ¥3.70B ¥5.02B ¥4.44B ¥4.52B ¥5.34B ¥0.00M
GM % Gross Margin %
30.61% 33.24% 38.68% 53.78% 60.13% 73.70% 76.69% 67.29% 56.44% 58.20% 60.66% 56.21% 60.00% 61.10% 65.03% 63.62% 72.03% 65.33% 62.38% 67.67% 0.00%
OM Operating Margin
16.00% 17.02% 26.40% 36.74% 48.25% 63.01% 64.44% 45.02% 30.95% 41.28% 40.90% 39.04% 40.28% 35.05% 37.44% 38.97% 39.78% 35.76% 27.08% 33.89% 0.00%
EPS Earnings Per Share
¥0.03 ¥0.05 ¥0.06 ¥0.10 ¥0.33 ¥0.33 ¥0.20 ¥0.14 ¥0.23 ¥0.25 ¥0.28 ¥0.37 ¥0.42 ¥0.55 ¥0.63 ¥0.81 ¥0.66 ¥0.49 ¥0.69 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.06 ¥0.00 ¥0.04 ¥0.03 ¥0.13 ¥0.19 ¥0.13 ¥0.21 ¥0.15 ¥0.21 ¥0.31 ¥0.30 ¥0.20 ¥0.30 ¥0.30 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 18.18% 0 20.00% 21.43% 56.52% 76.00% 46.43% 56.76% 35.71% 38.18% 49.21% 37.04% 30.30% 61.22% 43.48% 0
Sha. Shares
1733.86m 1733.86m 1733.86m 1733.86m 1797.76m 1797.76m 1797.76m 1797.76m 1797.76m 1797.76m 1813.67m 1813.67m 1813.67m 1813.67m 1813.67m 1823.98m 1824.37m 1824.37m 1824.37m 0m 1828.78m
OCF Operating Cash Flow
¥0.00M ¥98.24M ¥131.43M ¥179.02M ¥161.18M ¥607.73M ¥609.53M ¥335.93M ¥494.69M ¥510.70M ¥497.15M ¥548.62M ¥329.94M ¥177.42M ¥1.29B ¥1.36B ¥1.33B ¥1.43B ¥957.31M ¥1.35B ¥0.00M
FCF Free Cash Flow
¥0.00M ¥39.65M ¥-70.54M ¥-34.90M ¥34.36M ¥448.24M ¥459.88M ¥192.80M ¥347.54M ¥261.80M ¥358.93M ¥319.39M ¥109.58M ¥76.09M ¥1.11B ¥1.09B ¥703.96M ¥622.06M ¥613.69M ¥1.81B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.02 ¥-0.04 ¥-0.02 ¥0.02 ¥0.25 ¥0.26 ¥0.11 ¥0.19 ¥0.15 ¥0.20 ¥0.18 ¥0.06 ¥0.04 ¥0.61 ¥0.60 ¥0.39 ¥0.34 ¥0.31 ¥0.32 ¥0.00